ZA969220B - Nucleoside derivatives and process for preparing the same - Google Patents

Nucleoside derivatives and process for preparing the same

Info

Publication number
ZA969220B
ZA969220B ZA969220A ZA969220A ZA969220B ZA 969220 B ZA969220 B ZA 969220B ZA 969220 A ZA969220 A ZA 969220A ZA 969220 A ZA969220 A ZA 969220A ZA 969220 B ZA969220 B ZA 969220B
Authority
ZA
South Africa
Prior art keywords
preparing
same
nucleoside derivatives
nucleoside
derivatives
Prior art date
Application number
ZA969220A
Other languages
English (en)
Inventor
Jung Woo Kim
Koo Hun Chung
Soon Kil Ahn
Hoe Joo Son
Byeong Seon Jeong
Original Assignee
Chong Kun Dang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chong Kun Dang Corp filed Critical Chong Kun Dang Corp
Publication of ZA969220B publication Critical patent/ZA969220B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA969220A 1995-11-02 1996-11-01 Nucleoside derivatives and process for preparing the same ZA969220B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR19950039340 1995-11-02

Publications (1)

Publication Number Publication Date
ZA969220B true ZA969220B (en) 1997-06-02

Family

ID=19432711

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA969220A ZA969220B (en) 1995-11-02 1996-11-01 Nucleoside derivatives and process for preparing the same

Country Status (9)

Country Link
US (1) US6072051A (ko)
EP (1) EP0882058A1 (ko)
JP (1) JPH11514642A (ko)
KR (1) KR100213932B1 (ko)
CN (1) CN1201463A (ko)
AU (1) AU7341896A (ko)
CA (1) CA2235598A1 (ko)
WO (1) WO1997016456A1 (ko)
ZA (1) ZA969220B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10238722A1 (de) 2002-08-23 2004-03-11 Bayer Ag Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse
WO2005003147A2 (en) 2003-05-30 2005-01-13 Pharmasset, Inc. Modified fluorinated nucleoside analogues
GB2439543A (en) * 2006-06-27 2008-01-02 Viruvation B V Polyoma viral vector production cell lines and nucleic acids expressing dsRNA viral sequences
EP2050757A1 (en) * 2007-10-10 2009-04-22 Cilag AG Method of producing 2' -deoxy-5-azacytidine (Decitabine)
EP2217602B1 (en) 2007-11-30 2018-08-29 Boehringer Ingelheim International GmbH 1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-one derivatives and their use as pde9a modulators for the treatment of cns disorders
BRPI0907435A8 (pt) * 2008-01-22 2019-01-29 Dow Agrosciences Llc derivados de 5-flúor pirimidina
UA105362C2 (en) 2008-04-02 2014-05-12 Бьорингер Ингельхайм Интернациональ Гмбх 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
WO2010047866A2 (en) * 2008-08-01 2010-04-29 Dow Agrosciences Llc Use of 5-fluorocytosine as a fungicide
EA201100446A1 (ru) 2008-09-08 2011-10-31 Бёрингер Ингельхайм Интернациональ Гмбх Пиразолопиримидины и их применение для лечения нарушений цнс
GEP20146098B (en) 2009-03-31 2014-05-27 Boehringer Ingelheim Int 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their usage as pde9a modulators
CN103052639B (zh) 2010-08-12 2016-02-17 贝林格尔.英格海姆国际有限公司 6-环烷基-1,5-二氢-吡唑并[3,4-d]嘧啶-4-酮衍生物及其作为PDE9A抑制剂的用途
US8809345B2 (en) 2011-02-15 2014-08-19 Boehringer Ingelheim International Gmbh 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
UA115462C2 (uk) 2012-12-28 2017-11-10 Адама Махтешім Лтд. Похідні n-(заміщеного)-5-фтор-4-іміно-3-метил-2-оксо-3,4-дигідропіримідин-1(2h)-карбоксилату
UA117743C2 (uk) 2012-12-28 2018-09-25 Адама Махтешім Лтд. N-(заміщені)-5-фтор-4-іміно-3-метил-2-оксо-3,4-дигідропіримідин-1(2h)-карбоксамідні похідні
MX2015008565A (es) 2012-12-31 2015-09-07 Dow Agrosciences Llc Derivados de 3-alquil-5-fluoro-4-sustituido-imino-3,4-dihidropirim idin-2(1h)-ona como fungicidas.
CN106749056B (zh) * 2017-01-19 2019-08-02 重庆大学 一种Bola型三氮唑核苷化合物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9003151D0 (sv) * 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
ZA923641B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides

Also Published As

Publication number Publication date
US6072051A (en) 2000-06-06
KR970027099A (ko) 1997-06-24
CA2235598A1 (en) 1997-05-09
CN1201463A (zh) 1998-12-09
KR100213932B1 (ko) 1999-08-02
WO1997016456A1 (en) 1997-05-09
AU7341896A (en) 1997-05-22
JPH11514642A (ja) 1999-12-14
EP0882058A1 (en) 1998-12-09

Similar Documents

Publication Publication Date Title
HK1016580A1 (en) Purine derivatives and processes for their preparation
SG43809A1 (en) 2-benzyl-polycyclic guanine derivatives and process for preparing them
HUP0000449A3 (en) N-subsituted dioxothiazolidylbenzamide derivatives and process for producing the same
HU9702345D0 (en) 3-hydroxy-pyridine-2-carboxylic-amide-ester derivatives and process for producing them
HUP9900318A3 (en) Process for preparing 4-aryl-piperidine derivatives
HUP9800555A3 (en) 3,3-diphenylallylamine derivatives and process for their preparation
ZA969220B (en) Nucleoside derivatives and process for preparing the same
GR3034910T3 (en) Pyridazinone derivatives and processes for preparing the same
ZA981976B (en) Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
AU6629496A (en) Antiviral agent and process for preparing the same
EP0638586A3 (en) Nucleoside derivatives and process for their preparation.
IL118992A (en) Process for preparing norbenzomorphan derivatives
HRP931016A2 (en) Thienothiazin derivatives, process for the preparation and application thereof
HU9603105D0 (en) Adenosine derivatives
IL134494A0 (en) 13-deoxyanthracycline derivatives and processes for preparing them
AU3710395A (en) Nucleoside derivatives and process for preparing thereof
SG47141A1 (en) Sulfonamide derivative and process for preparing the same
EP0775705A3 (en) Cyclopentenecarboxamide derivative, method for its preparation and bicycloamide derivative used in this method
GB2302691B (en) Oxaindene derivatives and process for the preparation thereof
HU9602080D0 (en) 12,13-epoxi-tylosin derivatives and process for producing them
GB9608199D0 (en) Pyrimide nucleoside derivatives
GB2329385B (en) (3-Oxoisoindolin-1-ylidine)propandinitrile derivatives and method for preparing the same
HUP9601520A2 (en) Substituted quinoline-intermediates and process for preparation the same
HUP9601521A2 (en) Substituted quinoline-intermediates and process for preparation the same
NZ332994A (en) Iron-casein complex and process for preparing the same